glp-1 in heart failure receptor agonist-based therapies and cardiovascular risk: a review of mechanisms GLP-1 Receptor Agonists in Heart

ManneGoehler J, Teufel F, Venter WDF

[DOI] [PMC free article] [PubMed] [Google Scholar] 196.Abiola J.O., et al

GLP-1s: A Clear Weight Loss Advantage Studies have consistently shown that bariatric surgery provides up to five times more weight loss compared to GLP-1 medications

Conference on Retroviruses and Opportunistic Infections, Denver, abstract 695, 2026

In a cohort of patients who had undergone at least one prior line of anti-PD-(L)1 therapy, Balversa cut the risk of death by 36% versus chemotherapy

, we recently expanded on his insights in the Daily Journal, and the more we look at the data and real-world outcomes, the clearer it becomes: GLP-1s are changing how these cases are evaluated